Literature DB >> 28546331

Evaluation of Dual-Timepoint 18F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar Cancer.

Angela Collarino1,2, Giorgia Garganese3, Renato A Valdés Olmos2,4,5, Antonella Stefanelli6, Germano Perotti6, Paoletta Mirk7, Simona M Fragomeni3, Francesco P Ieria6, Giovanni Scambia3, Alessandro Giordano6, Vittoria Rufini6.   

Abstract

This study aimed to assess the value of dual-timepoint 18F-FDG PET/CT in the prediction of lymph node (LN) status in patients with invasive vulvar cancer (VC) scheduled for inguinofemoral LN dissection.
Methods: From April 2013 to July 2015, all consecutive patients with VC scheduled for inguinofemoral LN dissection were prospectively enrolled. All patients underwent a preoperative whole-body 18F-FDG PET/CT scan at 1 h (standard examination) and an additional scan from T11 to the groins at 3 h (delayed examination) after 18F-FDG injection. On both scans, each groin was visually scored 0 or 1 concerning 18F-FDG LN uptake relative to background. Semiquantitative analysis included SUVmax and the corresponding retention index of SUVmax, measured on both scans. The optimal cutoff value of these parameters was defined using a receiver-operating-characteristic analysis. Histopathology was the standard of reference.
Results: Thirty-three patients were included, with a total of 57 groins dissected and histologically evaluated. At histopathology, 21 of 57 (37%) groins contained metastatic LNs. Concerning visual score, sensitivity, specificity, negative predictive value, positive predictive value, and accuracy were 95.2%, 75%, 96.4%, 69%, and 82.5% on standard scanning and 95.2%, 77.8%, 96.6%, 71.4%, and 84.2% on delayed scanning, respectively. At receiver-operating-characteristic analysis, sensitivity and specificity were 95.2% and 77.8% on standard and delayed 18F-FDG PET/CT for an SUVmax cutoff of greater than 1.32 and 1.88, respectively, and 95.2% and 80% for a retention index of SUVmax cutoff of greater than 0.
Conclusion: Standard 18F-FDG PET/CT is an effective preoperative imaging method for the prediction of LN status in VC, allowing the prediction of pathologically negative groins and thus the selection of patients suitable for minimally invasive surgery. Delayed 18F-FDG PET/CT did not improve the specificity and the positive predictive value in our series. Larger studies are needed for a further validation.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG; FDG-retention index; dual time point PET/CT; groin lymph node metastasis; vulvar cancer

Mesh:

Substances:

Year:  2017        PMID: 28546331     DOI: 10.2967/jnumed.117.194332

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel.

Authors:  Angela Collarino; Valentina Fuoco; Giorgia Garganese; Lenka M Pereira Arias-Bouda; Germano Perotti; Gianpiero Manca; Sergi Vidal-Sicart; Francesco Giammarile; Lioe-Fee de Geus-Oei; Giovanni Scambia; Alessandro Giordano; Renato A Valdés-Olmos; Marco Maccauro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

2.  Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.

Authors:  Xiaolin Lu; Peipei Zhang; Yao Zhu; Dingwei Ye
Journal:  Oncol Lett       Date:  2019-01-14       Impact factor: 2.967

3.  Pelvic Exenteration for the Treatment of Locally Advanced Vulvar Cancer in South West Wales.

Authors:  Ganiy Opeyemi Abdulrahman; Nagindra Das; Thipparajapura V Chandrasekaran; Umesh Khot; Peter J Drew; Pradeep Bose; Jessica N Vet; Nasima Tofazzal; Shaun Roberts; Kerryn Lutchman Singh
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

Review 4.  The Role of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: A Systematic Review and Meta-Analysis.

Authors:  Debora Verri; Francesca Moro; Simona Maria Fragomeni; Drieda Zaçe; Sonia Bove; Federica Pozzati; Benedetta Gui; Giovanni Scambia; Antonia Carla Testa; Giorgia Garganese
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

5.  Multiparametric Dual-Time-Point [18F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma.

Authors:  Matthias Weissinger; Stefan Kommoss; Johann Jacoby; Stephan Ursprung; Ferdinand Seith; Sascha Hoffmann; Konstantin Nikolaou; Sara Yvonne Brucker; Christian La Fougère; Helmut Dittmann
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

6.  Radiomics in vulvar cancer: first clinical experience using 18F-FDG PET/CT images.

Authors:  Angela Collarino; Giorgia Garganese; Simona M Fragomeni; Lenka M Pereira Arias-Bouda; Francesco P Ieria; Ronald Boellaard; Vittoria Rufini; Lioe-Fee de Geus-Oei; Giovanni Scambia; Renato A Valdés Olmos; Alessandro Giordano; Willem Grootjans; Floris H P van Velden
Journal:  J Nucl Med       Date:  2018-07-20       Impact factor: 10.057

7.  Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT.

Authors:  Giorgia Garganese; Luca Tagliaferri; Simona Maria Fragomeni; Valentina Lancellotta; Giuseppe Colloca; Giacomo Corrado; Stefano Gentileschi; Gabriella Macchia; Enrica Tamburrini; Maria Antonietta Gambacorta; Anna Fagotti; Giovanni Scambia
Journal:  J Cancer Res Clin Oncol       Date:  2020-07-12       Impact factor: 4.553

8.  The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma.

Authors:  Giorgia Garganese; Frediano Inzani; Simona Maria Fragomeni; Giulia Mantovani; Luigi Della Corte; Alessia Piermattei; Angela Santoro; Giuseppe Angelico; Luciano Giacò; Giacomo Corrado; Anna Fagotti; Gian Franco Zannoni; Giovanni Scambia
Journal:  Cancers (Basel)       Date:  2021-12-19       Impact factor: 6.639

9.  Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study.

Authors:  Vittoria Rufini; Giorgia Garganese; Francesco P Ieria; Tina Pasciuto; Simona M Fragomeni; Benedetta Gui; Anita Florit; Frediano Inzani; Gian Franco Zannoni; Giovanni Scambia; Alessandro Giordano; Angela Collarino
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-23       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.